Ionis Pharmaceuticals Inc IONS:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 11:53 AM EST
52.69quote price arrow down-0.09 (-0.17%)
Volume
290,705
52 week range
39.32 - 64.37

...

Loading . . .

KEY STATS

  • Open52.78
  • Day High54.00
  • Day Low51.66
  • Prev Close52.78
  • 52 Week High64.37
  • 52 Week High Date01/26/21
  • 52 Week Low39.32
  • 52 Week Low Date03/23/20
  • Market Cap7.422B
  • Shares Out140.86M
  • 10 Day Average Volume0.94M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • 1 Year % Change-1.56

RATIOS/PROFITABILITY

  • EPS (TTM)-3.23
  • P/E (TTM)-16.33
  • Fwd P/E (NTM)-61.99
  • EBITDA (MRQ)-156.655M
  • ROE (MRQ)-39.00%
  • Revenue (MRQ)729.26M
  • Gross Margin (MRQ)98.36%
  • Net Margin (MRQ)-66.75%
  • Debt To Equity (MRQ)97.50%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Ionis Pharmaceuticals Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company, using its drug discovery platform, has developed a pipeline of drugs for patients with unmet medical needs. The Company's segments include Ionis Core and Akcea Therapeutics. In the Ionis Core segment, the Company is engaged in exploiting a drug discovery platform to generate a pipeline of drugs for the Company and its partners. The Akcea Therapeutics...
Stanley Crooke M.D. Ph.D.
Chairman
Brett Monia Ph.D.
Chief Executive Officer
Elizabeth Hougen
Chief Financial Officer
Eugene Schneider M.D.
Executive Vice President
Address
2855 Gazelle Ct
Carlsbad, CA
92010-6670
United States